Correlation Between Janux Therapeutics and Rezolute

Can any of the company-specific risk be diversified away by investing in both Janux Therapeutics and Rezolute at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Janux Therapeutics and Rezolute into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Janux Therapeutics and Rezolute, you can compare the effects of market volatilities on Janux Therapeutics and Rezolute and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Janux Therapeutics with a short position of Rezolute. Check out your portfolio center. Please also check ongoing floating volatility patterns of Janux Therapeutics and Rezolute.

Diversification Opportunities for Janux Therapeutics and Rezolute

0.7

Correlation Coefficient

Janux Therapeutics  Rezolute

Poor diversification

The 3 months correlation between Janux and Rezolute is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Janux Therapeutics and Rezolute in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rezolute and Janux Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Janux Therapeutics are associated (or correlated) with Rezolute. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rezolute has no effect on the direction of Janux Therapeutics i.e., Janux Therapeutics and Rezolute go up and down completely randomly.

Pair Corralation between Janux Therapeutics and Rezolute

Given the investment horizon of 90 days Janux Therapeutics is expected to under-perform the Rezolute. But the stock apears to be less risky and, when comparing its historical volatility, Janux Therapeutics is 1.22 times less risky than Rezolute. The stock trades about -0.03 of its potential returns per unit of risk. The Rezolute is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  470.00  in Rezolute on September 4, 2024 and sell it today you would earn a total of  40.00  from holding Rezolute or generate 8.51% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Janux Therapeutics  vs.  Rezolute

Janux Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Janux Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Janux Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Rezolute

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Rezolute are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting essential indicators, Rezolute unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Janux Therapeutics and Rezolute

The main advantage of trading using opposite Janux Therapeutics and Rezolute positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Janux Therapeutics position performs unexpectedly, Rezolute can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rezolute will offset losses from the drop in Rezolute's long position.

The idea behind Janux Therapeutics and Rezolute pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.